2015•Unpublished venueRequires access

Study on pure red cell aplastic lymphocyte subsets characteristics and the effect of cyclosporin A

Zengsheng Wang, Qin Miao Huang, Liu Hong, Ling Fu

Open publisher page 0 citations

Abstract

Objective To detect and analyse acquired pure red cell aplasia (PRCA) T lymphocyte subsets distribution and to assess its condition and cyclosporine immune function of T lymphocytes subsets. Methods Flow cytometry was applicated to detect peripheral blood T lymphocyte subsets of acquired PRCA patients before and after 3 months of treatment with cyclosporine-based immunosuppressive regimen and normal controls. Results Among 22 patients, 17 cases of blood returning normal (three cases of bone marrow returning normal), the total effective rate was 95.5 % (3 cases of cure, 14 cases of remission, 4 cases of improvement, 1 case of ineffectiveness). Th (CD3+ CD4+) cells and Th/Ts ratios in acquired PRCA patient group were lower than those in the normal control group, while Ts (CD3+ CD8+) cells was higher than that in the normal control group, the differences were statistically significant (P< 0.05). After 3 months of treatment, Th cells and Th/Ts ratio were higher than those before, and Ts cells were decreased compared with the previous (P< 0.05). Conclusion Disorders of T lymphocyte subsets in acquired PRCA patients lead to immune dysfunction, however, cyclosporine can improve T lymphocyte subsets in patients with imbalance, which is an effective way to treat the disease with significant curative effect and mild adverse reactions. Key words: Acquired pure red cell aplastic; T lymphocytes; Cyclosporine

About this research paper

What this paper is about

Objective To detect and analyse acquired pure red cell aplasia (PRCA) T lymphocyte subsets distribution and to assess its condition and cyclosporine immune function of T lymphocytes subsets. Methods Flow cytometry was applicated to detect peripheral blood T lymphocyte subsets of acquired PRCA patients before and after 3 months of treatment with cyclosporine-based immunosuppressive regimen and normal controls. Results Among 22 patients, 17 cases of blood returning normal (three cases of bone marrow returning normal), the total effective rate was 95.5 % (3 cases of cure, 14 cases of remission, 4 cases of improvement, 1 case of ineffectiveness). Th (CD3+ CD4+) cells and Th/Ts ratios in acquired PRCA patient group were lower than those in the normal control group, while Ts (CD3+ CD8+) cells was higher than that in the normal control group, the differences were statistically significant (P< 0.05). After 3 months of treatment, Th cells and Th/Ts ratio were higher than those before, and Ts cells were decreased compared with the previous (P< 0.05). Conclusion Disorders of T lymphocyte subsets in acquired PRCA patients lead to immune dysfunction, however, cyclosporine can improve T lymphocyte subsets in patients with imbalance, which is an effective way to treat the disease with significant curative effect and mild adverse reactions. Key words: Acquired pure red cell aplastic; T lymphocytes; Cyclosporine

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect and analyse acquired pure red cell aplasia (PRCA) T lymphocyte subsets distribution and to assess its condition and cyclosporine immune function of T lymphocytes subsets. Methods Flow cytometry was applicated to detect peripheral blood T lymphocyte subsets of acquired PRCA patients before and after 3 months of treatment with cyclosporine-based immunosuppressive regimen and normal controls. Results Among 22 patients, 17 cases of blood returning normal (three cases of bone marrow returning normal), the total effective rate was 95.5 % (3 cases of cure, 14 cases of remission, 4 cases of improvement, 1 case of ineffectiveness). Th (CD3+ CD4+) cells and Th/Ts ratios in acquired PRCA patient group were lower than those in the normal control group, while Ts (CD3+ CD8+) cells was higher than that in the normal control group, the differences were statistically significant (P< 0.05). After 3 months of treatment, Th cells and Th/Ts ratio were higher than those before, and Ts cells were decreased compared with the previous (P< 0.05). Conclusion Disorders of T lymphocyte subsets in acquired PRCA patients lead to immune dysfunction, however, cyclosporine can improve T lymphocyte subsets in patients with imbalance, which is an effective way to treat the disease with significant curative effect and mild adverse reactions. Key words: Acquired pure red cell aplastic; T lymphocytes; Cyclosporine

Key concepts: CD8, Medicine, Lymphocyte subsets, Pure red cell aplasia, Immune system, CD3, Lymphocyte, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pure red cell aplastic lymphocyte subsets characteristics and the effect of cyclosporin A — Research Paper | ScholarLens